Merluzzi Vj

Phase I trial of recombinant interleukin-2 and cyclophosphamide: augmentation of cellular immunity and T-cell mitogenic response with long-term administration of rIL-2.

Kolitz Je, Wong Gy, Karl Welte et al. · PubMed · 1988 · 35 citations

Immunology, Immunologic Mechanism, Pharmacotherapy +22

Recovery of the in vivo cytotoxic T-cell response in cyclophosphamide-treated mice by injection of mixed-lymphocyte-culture supernatants.

Merluzzi Vj, Kenney Re, Schmid Fa et al. · PubMed · 1981 · 33 citations

Radiation Oncology, Cyclophosphamide Treatment, Cell Therapy +15

Evaluation of zinc complexes on the replication of rhinovirus 2 in vitro.

Merluzzi Vj, Dana Cipriano, Daniel W. McNeil et al. · PubMed · 1989 · 19 citations

Rhinovirus 2, Virus Structure, Viral Replication +13

Expansion of activated T-lymphocytes in patients treated with recombinant interleukin 2.

Kolitz Je, Karl Welte, Wong Gy et al. · PubMed · 1987 · 15 citations

Il 2, Lymphocyte Development, T-regulatory Cell +17